New Zealand community pharmacists' views of their roles in meeting medicine-related needs for people with mental illness

Research in Social and Administrative Pharmacy

Volumn 7, Issue 2, 2011, Pages 122-133

  Crump, Keith ^a,b   Boo, Guobin ^b   Liew, Fung Shin ^b   Olivier, Tracy ^b   So, Cecilia ^b   Sung, Jae Yong ^b   Wong, Chi Hang ^b   Shaw, John ^b   Wheeler, Amanda ^a,b  

^a WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Community pharmacy; Mental health; Pharmacy services

Indexed keywords

ARTICLE; HEALTH CARE DELIVERY; HUMAN; MENTAL DISEASE; NEW ZEALAND; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; QUALITATIVE RESEARCH;

COMMUNITY PHARMACY SERVICES; DELIVERY OF HEALTH CARE; HUMANS; MENTAL DISORDERS; NEW ZEALAND; PHARMACISTS; PROFESSIONAL ROLE; QUALITATIVE RESEARCH;

EID: 79956284305     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2010.03.006     Document Type: Article

References (66)

1. World Health Organization (WHO) The World Health Report 2001: Mental Health: New Understanding, New Hope 2001, WHO, Geneva, Switzerland.
2. World Health Organization The global burden of disease: 2004 update Available at:, Accessed 09.03.2010. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.
3. Wells J.E., Browne M.A.O., Scott K.M., et al. Te Rau Hinengaro: the New Zealand Mental Health Survey: overview of methods and findings. Aust N Z J Psychiatry 2006, 40:835-844.
4. Scott K.M., Browne M.A.O., McGee M.A., Wells J.E. Mental-physical comorbidity in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust N Z J Psychiatry 2006, 40:882-888.
5. World Health Organization and World Organization of Family Doctors (Wonca) Integrating mental health into primary care: a global perspective Available at:, Accessed 09.03.2010. http://whqlibdoc.who.int/publications/2008/9789241563680_eng.pdf.
6. Wilson J. Mental health services in New Zealand. Int J Law Psychiatry 2000, 23:215-228.
7. World Health Organization Mental Health Gap Action Programme: scaling up care for mental, neurological and substance use disorders Available at:, Accessed 09.03.2010. http://whqlibdoc.who.int/publications/2008/9789241596206_eng.pdf.
8. Mental Health Commission Our Lives in 2014: A Recovery Vision from People with Experience of Mental Illness for the Second Mental Health Plan and the Development of the Health and Social Sectors 2004, Mental Health Commission, Wellington, New Zealand.
9. Keks N.A., Altson K., Hope J., et al. Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service. Aust N Z J Psychiatry 1999, 33:896-901.
10. Owen R.R., Feng W., Thrush C.R., Hudson T.J., Austen M.A. Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals. Psychiatr Serv 2001, 52:1523-1525.
11. Owen R.R., Thrush C.R., Kirchner J.E., Fischer E.P., Booth B.M. Performance measurement for schizophrenia: adherence to guidelines for antipsychotic dose. Int J Qual Health Care 2000, 12:475-482.
12. Mort J.R., Aparasu R.R. Prescribing of psychotropics in the elderly: why is it so often inappropriate?. CNS Drugs 2002, 16:99-109.
13. Leslie D.L., Rosenheck R.A. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector. J Ment Health Policy Econ 2003, 6:113-121.
14. Meagher D., Moran M. Sub-optimal prescribing in an adult community mental health service: prevalence and determinants. Psychiatr Bull 2003, 27:266-270.
15. Harrington M., Lelliott P., Paton C., Konsolaki M., Sensky T., Okocha C. Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatr Bull 2002, 26:418-420.
16. Paton C., Lelliott P., Harrington M., Okocha C., Sensky T., Duffett R. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients. J Psychopharmacol 2003, 17:223-229.
17. Taylor D., Mir S., Kerwin R. Prescribing in schizophrenia. Evaluating the effect of introducing a new treatment protocol. Psychiatr Bull 2000, 24:106-108.
18. Adams J., Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand 2000, 101:119-124.
19. Cramer J.A., Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998, 49:196-201.
20. Gray R., Wykes T., Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs 2002, 9:277-284.
21. Allen M.H., Carpenter D., Sheets J.L., Miccio S., Ross R. What do consumers say they want and need during a psychiatric emergency?. J Psychiatr Pract 2003, 9:39-58.
22. Happell B., Manias E., Roper C. Wanting to be heard: mental health consumers' experiences of information about medication. Int J Ment Health Nurs 2004, 13:242-248.
23. Howard P.B., El-Mallakh P., Kay Rayens M., Clark J.J. Consumer perspectives on quality of inpatient mental health services. Arch Psychiatr Nurs 2003, 17:205-217.
24. Gray R., Rofail D., Allen J., Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs 2005, 52:31-37.
25. Black E., Murphy A.L., Gardner D.M. Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatr Serv 2009, 60:1123-1127.
26. Maslen C.L., Rees L., Redfern P.H. Role of the community pharmacist in the care of patients with chronic schizophrenia in the community. Int J Pharm Pract 1996, 4:187-195.
27. Phokeo V., Sproule B., Raman-Wilms L. Community pharmacists' attitudes toward and professional interactions with users of psychiatric medication. Psychiatr Serv 2004, 55:1434-1436.
28. Chapman J.L., Zechel A., Carter Y.H., Abbott S. Systematic review of recent innovations in service provision to improve access to primary care. Br J Gen Prac 2004, 54:374-381.
29. Garfield S., Smith F., Francis S.A. From black clouds to lighter grey: how pharmacists can help in depression. Pharm J 2004, 272:576-577.
30. Wagner E.H. The role of patient care teams in chronic disease management. Br Med J 2000, 320:569-572.
31. Hepler C., Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Health Syst Pharm 1990, 47:533-543.
32. Urbis Keys Young Evaluation of the Home Medicines Review Program (pharmacy component) Available at:, Accessed 21.12.2009. http://www.guild.org.au/uploadedfiles/Medication_Management_Reviews/Overview/Urbis%20Keys%20Young%20evaluation.pdf.
33. Shaw J., Seal R., Pilling M. Room for review: a guide to medication review: the agenda for patients, practitioners and managers Available at:, Accessed 21.12.2009. http://www.keele.ac.uk/schools/pharm/npcplus/medicinespartner/documents/room_for_review.pdf.
34. Ministry of Health Towards a New Zealand medicines strategy: consultation document Available at:, Accessed 21.12.2009. http://www.moh.govt.nz/moh.nsf/pagesmh/5633/$File/towards-newzealand-medicines-strategy-consult.pdf.
35. District Health Boards New Zealand New Zealand National Pharmacist Services Framework: Version 1 DHBNZ Pharmacy Advisory Group, Available at:, Accessed 21.12.2009. http://www.dhbnz.org.nz/Site/SIG/NPSF/NPSF-Framework.aspx.
36. Pharmacy Council of New Zealand Medicines management. Definition, levels, competence framework [pdf] Available at:, Accessed 21.12.2009. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=44.
37. Maidment I., Taylor D.A., Branford D. " Talking about medicines" -agreeing on the way forward. Hosp Pharmacist 2007, 14:74.
38. Wheeler A.J., Al-Jumaily J., Lee D.L.W., et al. Knowing what we don't know: a learning needs analysis for CPD in optimal use of medicines in mental health. Pharm J NZ 2009, 2:18-24.
39. Fontana A., Frey J.H. The interview: from neural stance to political involvement. Sage Handbook of Qualitative Research 2005, 695-728. Sage Publications, Inc., London, UK. 3rd ed. N.K. Denzin, Y.S. Lincoln (Eds.).
40. Walker R.A., Martin S. Demographic Profile for Waitemata DHB: An Analysis of the 2006 Census 2007, Waitemata District Health Board, Auckland, New Zealand.
41. Te Rau Hinengaro: The New Zealand Mental Health Survey 2006, Ministry of Health, Wellington, New Zealand. M. Oakley-Browne, J. Wells, K. Scott (Eds.).
42. Hauora: Maori Standards of Health IV. A Study of the Years 2000-2005 2007, Te Ropu Rangahau Hauora a Eru Pomare, Wellington, New Zealand. B. Robson, R. Harris (Eds.).
43. Waitangi Tribunal Treaty of Waitangi Available at:, Accessed 12.01.2010. http://www.waitangi-tribunal.govt.nz/treaty/meaning.asp.
44. Thomas D.R. A general inductive approach for analyzing qualitative evaluation data. Am J Eval 2006, 27:237-246.
45. Ministry of Health The primary care strategy Available at:, Accessed 12.01.2010. http://www.moh.govt.nz/moh.nsf/0/7BAFAD2531E04D92CC2569E600013D04/$File/PHCStrat.pdf.
46. Schneider P., Murphy J., Pedersen C. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc 2008, 48:58-63.
47. Huang H., Maguire M., Miller E., Appel L. Impact of pill organizers and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol 2000, 152:780-787.
48. Sleath B., Wurst K., Lowery T. Drug information sources and antidepressant adherence. Comm Mental Health J 2003, 39:359-368.
49. Tinelli M., Bond C., Blenkinsopp A., Jaffray M., Watson M., Hannaford P. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother 2007, 41:1962-1970.
50. Crockett J., Taylor S., Grabham A., Stanford P. The Role of the Community Pharmacist in the Management of Depression (Report Prepared for The Pharmacy Guild of Australia) 2005, University of Sydney, Sydney, Australia.
51. Fenton W.S., Blyer C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997, 23:637-651.
52. Garfield S., Francis S., Smith F. Building concordant relationships with patients starting antidepressant medication. Patient Educ Couns 2004, 55:241-246.
53. Airaksinen M., Ahonen R., Enlund H. Customer feedback as a tool for improving pharmacy services. Int J Pharm Pract 1995, 3:219-226.
54. Benson M., Cribb A. In their own words: community pharmacists and their health education role. Int J Pharm Pract 1995, 3:74-77.
55. Matheson C., Bond C. Motivations for and barriers to community pharmacy services for drug misusers. Int J Pharm Pract 1999, 7:256-263.
56. Zweber A. Cultural competence in pharmacy practice. Am J Pharm Educ 2002, 66:172-176.
57. Baxter J., Kokaua J., Wells J.E., McGee M.A., Browne M.A.O. Ethnic comparisons of the 12 month prevalence of mental disorders and treatment contact in Te Rau Hinengaro: the New Zealand Mental Health Survey. Aust NZ J Psychiatry 2006, 40:905-913.
58. Pharmacy Council of New Zealand Cultural competence standards Available at:, Accessed 12.01.2010. http://www.pharmacycouncil.org.nz/cms_show_download.php,id=57.
59. Hughes C., McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003, 53:600-606.
60. Bell J.S., Aslani P., McLachlan A.J., Whitehead P., Chen T.F. Mental health case conferences in primary care: content and treatment decision making. Res Soc Adm Pharm 2007, 3:86-103.
61. Scahill S., Harrison J., Sheridan J. The ABC of New Zealand's ten year vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract 2009, 17:135-142.
62. Anderson C. Health promotion by community pharmacists: perceptions, realities and constraints. J Soc Adm Pharm 1998, 15:10-22.
63. Anderson C. Health promotion in community pharmacy: the UK situation. Patient Educ Couns 2000, 39:285-291.
64. Smith W., Ray M., Shannon D. Physicians' expectations of pharmacists. Am J Health Syst Pharm 2002, 59:50-57.
65. Rijcken C.A.W., van der Veur H., Knegtering H., de Jong-van den Berg L.T.W. Schizophrenia care and the Dutch community pharmacy: the unmet needs. Int J Pharm Pract 2003, 11:97-104.
66. Guba G.E., Lincoln Y.S. Paradigmatic controversies, contradictions and emerging confluences. Sage Handbook of Qualitative Research 2005, 191-216. Sage Publications, Inc., London, UK. 3rd edn. N.K. Denzin, Y.S. Lincoln (Eds.).